Medindia
Medindia LOGIN REGISTER
Advertisement

GSK invests $100 million to expand long-term vaccine manufacturing capabilities in Hamilton, MT

Wednesday, April 24, 2019 General News
Advertisement
- Site expansion will boost vaccine production capacity

GSK enquiries:

US Media enquiries:

Kristen Neese  

+1 804 217 8147

(Philadelphia)

Sean Clements  

+ 215 740 3088

(Philadelphia)

UK media enquiries:   

Simon Moore

+44 (0) 20 8047 5502

(London)

Analyst/Investor enquiries:  

Sarah Elton-Farr

+44 (0) 20 8047 5194

(London)

James Dodwell

+44 (0) 20 8047 2406

(London)  

Danielle Smith

+44 (0) 20 8047 2406

(London)

Jeff McLaughlin  

+1 215 751 7002

(Philadelphia)  

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close